期刊文献+

大鼠动脉粥样硬化形成过程中TAFI水平变化及作用机制 被引量:4

TAFI level and its mechanism in the process of atherosclerosis in rats
暂未订购
导出
摘要 目的:探讨在大鼠动脉粥样硬化(AS)形成过程中凝血酶活化的纤维蛋白溶解抑制剂(TAFI)活性水平变化及作用机制。方法:将40只健康的雄性Wistar大鼠随机分为正常对照组、高脂组、高脂维生素D3组和内皮损伤组,每组10只。分别以普通饲料、高脂饲料、高脂饲料+维生素D3负荷、高脂饲料+维生素D3负荷+内皮球囊损伤处理4个月,复制大鼠动脉粥样硬化形成过程中三个阶段的模型,即高脂血症、纤维增生性动脉硬化、较成熟的AS斑块病变。模型建造前,自颈动脉取血,模型建造成功后,自下腔静脉取血,用全自动生化仪测定血浆总胆固醇(TC)、总甘油三脂(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C),发色底物法测定血浆TAFI的活性,分析TAFI活性以及血脂指标在造模前、后不同组间的变化。结果:①成功复制了大鼠动脉粥样硬化发展过程中高脂血症期、纤维增生性动脉硬化期、较成熟的斑块期的模型;②高脂组、高脂维生素D3组和内皮损伤组大鼠的TC、TG、LDL-C水平和TAFI活性明显高于正常对照组(P<0.01),且有递增趋势,以内膜损伤组升高最为明显;三组模型鼠的HDL-C水平明显低于正常对照组(P<0.01或P<0.05),且有递减趋势,以内膜损伤组降低最为明显;③血浆TAFI活性与TC和TG水平呈正相关。结论:AS过程中,TAFI水平呈逐渐增高趋势,提示AS的病变程度与血浆TAFI水平密切相关。 Objective: To investigate the level of TAFI and its mechanism on atherosclerosis. Methods: Forty healthy male Wistar rats were randomly divided into 4 groups (n = 10): the control group, the high lipid group, the high lipid + Vitamin D overload group, and the endothelium injury group. Then the content of TC, TG, HDL-C, and LDL-C and the activity of TAFI were determined by a ehromogenie assay. Results: Atheroselerosis was successfully established. Hyperlipoidemia stage, fiber hyperplasy arteriosclerosis stage and maturatly plaque stage were also success- fully duplicated. TC, TG, LDL-C and the activity of TAFI in the plasma of the three model groups gradually increased compared with the control group ( P 〈0.01). However, HDL-C in the plasma of the three model groups gradually decreased compared with the control group( P 〈0.01 or P 〈0.05). The activity of TAFI in the plasma positively related to TG and TC. Conclusion: The activity of TAFI in the plasma is closely correlated with atheroselerosis severity.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第8期787-791,共5页 Journal of Shandong University:Health Sciences
基金 山东省科技发展计划项目(2006GG2202045)
关键词 动脉硬化 凝血酶活化的纤维蛋白溶解抑制剂 内皮 损伤 大鼠 Wistar Atherosclerosis Thrombin activatable fibrinolysis inhibitor Endothelium Injuries Rats, Wistar
  • 相关文献

参考文献8

  • 1张松江,史绍蓉,邬力祥.凝血纤溶系统与动脉粥样硬化血栓形成的关系及运动对其的影响[J].现代预防医学,2006,33(12):2316-2319. 被引量:6
  • 2Schroeder V,Chatterjee T,Mehta H,et al.Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography[J].Thromb Haemost,2002,88(6):1020-1025.
  • 3Fonseca FA,Paiva TB.Dietary magnesium improves endothelial dependent relaxation of balloon injured arteries in rats[J].Atherosclerosis,1998,139(2):237-242.
  • 4郭延松,吴宗贵,杨军柯,黄高忠.三种大鼠动脉粥样硬化模型复制方法的比较[J].中国动脉硬化杂志,2003,11(5):465-469. 被引量:89
  • 5Santamaria A,Borrell M,Oliver A,et al.Association of functional thrombin activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population[J].Am J Hematology,2004,76(4):348-352.
  • 6Hosaka Y,Takahashi Y,Ishii H,et al.Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B[J].Thromb Haemost,1998,79(2):371-377.
  • 7Boffa MB,Wang W,Bajzar L,et al.Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation,thrombin/thrombomodulin-dependent activation,thermal stability,and enzymatic properties[J].J Biol Chem,1998,273(4):2127-2135.
  • 8Wang W,Boffa MB,Bajzar L,et al.A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor[J].J Biol Chem,1998,273(42):27176-27181.

二级参考文献40

共引文献92

同被引文献75

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部